Category: Intellectual property
-

Biotech Options Enzyme Inhibitors for Lung Cancer
A biotechnology company developing inhaled drugs for respiratory diseases agreed to provide Johnson & Johnson with access to its technology for treating lung cancer.
-

Engineered Viruses Licensed for Cancer Therapies
A biotechnology company developing cancer immunotherapies with synthetic viruses is licensing its technology to Takeda Pharmaceuticals.
-

Engineered Virus Aids Gene Therapy Delivery
A university bio-engineering lab and start-up company are developing synthetic variations of viruses to more reliably deliver gene therapies.
-

Biotech Licenses Gene-Limiting Technology for Allergies
A biotechnology company developing treatments for skin conditions is acquiring a technology for limiting effects of genes causing asthma and allergic reactions.
-

Company, Univ. Lab Partner on Skin Disease Treatment
A company making regenerative skin therapies and a medical school research center are developing a spray-on treatment for a genetic skin disorder.
-

FDA Tags Biofilm Disruption Device as Breakthrough
A system using an electric current to break up bacterial communities on orthopedic implants received a breakthrough-device designation from the Food and Drug Administration.
-

Trial Shows Nanotech Drug Induces Gluten Tolerance
Results from a clinical trial show an experimental treatment encourages immune-system tolerance of gluten, preventing intestinal damage from celiac disease.
-

Merck Gaining Gut Microbe Technology for Vaccines
Drug maker Merck & Co. is partnering with a developer of treatments for disease derived from microbes in the gut, for discovery of up to three vaccines.
-

Biotech Developing Genome-Adjusting Disease Treatments
A new biotechnology enterprise is creating disease treatments that address regions in the genome precisely regulating expression of proteins.
-

Start-Up Targets Extra DNA in Cancer, Raises $46.4M
A new biotechnology enterprise is developing treatments for aggressive solid tumor cancers that block the effects of DNA residing outside of chromosomes.